Dear Mother Nature provides an insightful and unique opportunity to end the taboo against menstruation, and open up the conversation surrounding period poverty. In early 2021, Leading Light were awarded the Bread & Roses Theatre Emerging Company Award, for which they were offered funding and a space to continue the R&D for Dear Mother Nature, which took place in late March, and involved discussions, script work and character development with two of the original cast members.
They are delighted to announce to have been awarded Arts Council England funding to progress to the next stage of R&D of ‘Dear Mother Nature’, taking place at the end of August. They now strive to bring the project beyond its digital medium and into a full live production, and eventually onto the stage. The purpose of Dear Mother Nature is to educate and normalise the conversation surrounding menstruation and period poverty. The company intends to build on the partnership already created with period charity Ditch The Rag
They are ring-fencing a proportion of this funding to offer a £3,000 seed commission to a writer for this next stage.
This opportunity is open to anyone who menstruates, and/or has lived experience of menstruation.
- A seed commission for a treatment, and three five-minute monologues, which will be developed – with support – into two drafts of a 40 minute script
- A week-long R&D of your work.
- Tailored dramaturgical advice and mentoring sessions with Macadie Amoroso.
- The opportunity to have your work professionally produced.
Monday 26th July, 12pm
Friday 30th July – shortlisted applicants to be invited to interview
Tuesday 3rd and Thursday 5th August – interviews, with a possibility of a second interview on the morning of Friday 6th August
W/C 9th August – regular sessions between you and production team begin
W/C Monday 23rd August – R&D (five days), you will be required to attend two days in person.
Wednesday 30th September – 40 minute script deadline
You must be available for regular sessions from Monday 9th August, and to attend two R&D days in-person.